Chabiotech Co.,Ltd. (KOSDAQ:085660)
12,210
-130 (-1.05%)
Nov 7, 2025, 3:30 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 927.42 billion as of November 10, 2025. Its market cap has decreased by -4.42% in one year.
Market Cap
927.42B
Enterprise Value
1.79T
Revenue
1.15T
Ranking
n/a
PE Ratio
n/a
Stock Price
12,210.00
Market Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 927.42B, an increase of 177.56%. That is a compound annual growth rate of 6.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 927.42B | 44.58% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | 1.05T | 39.68% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.09T |
| ALTEOGEN | 28.24T |
| SK Biopharmaceuticals | 9.08T |
| Yuhan | 8.62T |
| Peptron | 6.67T |
| HLB Co., Ltd. | 6.25T |
| ABL Bio | 5.58T |